Company Number: 14331594

Analysis Date: 2025-07-29 20:52 UTC

Financial Health Assessment for NAEEM ISMAIL LTD (as at 30 September 2024)

---

1. Financial Health Score: D

Explanation:
The company exhibits signs of financial distress, particularly in liquidity and working capital management. Although it remains operational and solvent on paper, the negative net current assets and minimal net equity highlight vulnerabilities. The score reflects a business with financial strain that requires urgent attention to cash flow and creditor management to avoid worsening conditions.

---

2. Key Vital Signs

Metric	Value (£) / Status	Interpretation (Medical Analogy)
Fixed Assets	12,378	Moderate investment in long-term assets—stable bone structure.
Current Assets	30,582	Cash + receivables are present but insufficient to cover short-term debts.
Cash	17,390	Reasonably healthy blood flow (cash on hand) but not enough to offset liabilities.
Debtors	13,192	Receivables have increased significantly—potential symptom of slow collections.
Current Liabilities	42,773	High short-term debts—the “infections” pressuring the system.
Net Current Assets (Working Capital)	-12,191	Negative working capital—a clear symptom of liquidity stress.
Net Assets (Equity)	187	Severely diminished immunity (shareholders’ equity), indicating fragile financial reserves.
Directors’ Loan Accounts	Net debtor balance (small amount)	Mixed signals—loans to directors are small but fluctuating, indicating cash movement within related parties.

---

3. Diagnosis: Financial Condition Overview

NAEEM ISMAIL LTD is an active private limited company operating as an unlicensed carrier. Its financials reveal several "symptoms" of distress:

• Negative Working Capital: The company’s current liabilities exceed current assets by over £12,000, indicating that it may struggle to meet its short-term obligations without external support or improved cash conversion. This is like a patient whose vital signs are unstable due to insufficient reserves to combat immediate threats.

• Erosion of Net Equity: Shareholders’ funds have dropped dramatically from £1,835 in 2023 to £187 in 2024. This severe reduction signals ongoing losses or distributions outpacing retained earnings, weakening the company’s financial immune system.

• Declining Fixed Assets: The company’s fixed assets have decreased due to depreciation and no new capital expenditure, which may indicate limited reinvestment in core operational capacity.

• Increase in Debtors: Trade and other debtors have increased substantially, which could indicate slower customer payments or credit policy issues. This is akin to a backlog of unresolved medical symptoms that could worsen if untreated.

• Stable Cash Position but Insufficient: Cash levels are stable but not sufficient to cover the high short-term liabilities, implying a liquidity crunch—comparable to a patient with adequate but barely sufficient blood flow struggling under increased stress.

• Directors' Loans: Movement in directors’ loan accounts suggests some cash flow management through related parties, which should be monitored carefully to avoid conflicts or mismanagement.

In summary, the company’s financial health is fragile and shows clear signs of liquidity risk and declining equity. While still operational, it is akin to a patient with a chronic condition needing immediate lifestyle changes and medical intervention to prevent deterioration.

---

4. Recommendations: Improving Financial Wellness

1. Improve Working Capital Management:

   • Accelerate debtor collections through stricter credit control and more aggressive follow-ups.
   • Negotiate extended payment terms with creditors to ease short-term cash flow pressure.
   • Consider offering early payment discounts to key customers to improve cash inflows.

2. Enhance Cash Flow Monitoring:

   • Implement rolling cash flow forecasts to anticipate liquidity shortages.
   • Restrict non-essential expenditures and delay capital investments unless absolutely necessary.

3. Strengthen Equity Base:

   • Inject additional capital if possible to shore up shareholders’ funds.
   • Explore options for short-term financing or overdraft facilities as a buffer against liquidity shocks.

4. Review Directors’ Loans and Related Party Transactions:

   • Ensure transparency and formal documentation to avoid governance issues.
   • Directors should consider repaying any outstanding loans promptly to improve the company’s balance sheet.

5. Operational Efficiency:

   • Review operational costs and seek efficiencies to reduce overheads.
   • Investigate the causes of increased debtors and take corrective action to improve credit risk management.

6. Strategic Business Review:

   • Given the fragile financial condition, consider revisiting the business model, pricing strategy, and market positioning to boost profitability.

---